These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 31248605

  • 21. Commentary on "Inherited DNA-repair gene mutations in men with metastatic prostate cancer". Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016;375(5):443-53.
    Freedland SJ, Aronson WJ.
    Urol Oncol; 2017 Aug; 35(8):536-537. PubMed ID: 28623070
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
    Hamel N, Kotar K, Foulkes WD.
    BMC Med Genet; 2003 Aug 11; 4():7. PubMed ID: 12911837
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer.
    Januskevicius T, Vaicekauskaite I, Sabaliauskaite R, Matulevicius A, Vezelis A, Ulys A, Jarmalaite S, Jankevicius F.
    Medicina (Kaunas); 2023 Dec 30; 60(1):. PubMed ID: 38256334
    [Abstract] [Full Text] [Related]

  • 27. Germline genetics in localized prostate cancer.
    Ryan ST, Nguyen V, Bree KK, Holst DD, Kader AK.
    Curr Opin Urol; 2019 Jul 30; 29(4):326-333. PubMed ID: 31116139
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
    Takahashi H, Lu W, Watanabe M, Katoh T, Furusato M, Tsukino H, Nakao H, Sudo A, Suzuki H, Akakura K, Ikemoto I, Asano K, Ito T, Wakui S, Muto T, Hano H.
    Int J Cancer; 2003 Nov 01; 107(2):224-8. PubMed ID: 12949798
    [Abstract] [Full Text] [Related]

  • 31. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.
    Maia S, Cardoso M, Paulo P, Pinheiro M, Pinto P, Santos C, Pinto C, Peixoto A, Henrique R, Teixeira MR.
    Fam Cancer; 2016 Jan 01; 15(1):111-21. PubMed ID: 26289772
    [Abstract] [Full Text] [Related]

  • 32. Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients.
    Liang Y, Chiu PK, Zhu Y, Wong CY, Xiong Q, Wang L, Teoh JY, Cao Q, Wei Y, Ye DW, Tsui SK, Ng CF.
    PLoS Genet; 2022 Sep 01; 18(9):e1010373. PubMed ID: 36095024
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Molecular insights into the germline for prostate cancer initiation, progression, and aggressiveness.
    Pritchard CC.
    Can J Urol; 2019 Oct 01; 26(5 Suppl 2):24-26. PubMed ID: 31629422
    [Abstract] [Full Text] [Related]

  • 36. Germline BLM mutations and metastatic prostate cancer.
    Ledet EM, Antonarakis ES, Isaacs WB, Lotan TL, Pritchard C, Sartor AO.
    Prostate; 2020 Feb 01; 80(2):235-237. PubMed ID: 31816118
    [Abstract] [Full Text] [Related]

  • 37. A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
    Wu Y, Yu H, Zheng SL, Na R, Mamawala M, Landis T, Wiley K, Petkewicz J, Shah S, Shi Z, Novakovic K, McGuire M, Brendler CB, Ding Q, Helfand BT, Carter HB, Cooney KA, Isaacs WB, Xu J.
    Prostate; 2018 Jun 01; 78(8):607-615. PubMed ID: 29520813
    [Abstract] [Full Text] [Related]

  • 38. The relevance of BRCA genetics to prostate cancer pathogenesis and treatment.
    Sundararajan S, Ahmed A, Goodman OB.
    Clin Adv Hematol Oncol; 2011 Oct 01; 9(10):748-55. PubMed ID: 22252577
    [Abstract] [Full Text] [Related]

  • 39. Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.
    Ong PY, Poon SL, Tan KT, Putti TC, Ow SGW, Chen SJ, Chen CH, Lee SC.
    Gynecol Oncol; 2019 Nov 01; 155(2):275-279. PubMed ID: 31481248
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.